Status: current, Defined. Date: 31-Aug 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3968881000168112 | Glyxambi 10 mg/5 mg (empagliflozin 10 mg + linagliptin 5 mg) tablet, 30 tablets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3968891000168110 | Glyxambi 10 mg/5 mg tablet, 30 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Glyxambi 10 mg/5 mg tablet, 30 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Glyxambi 10 mg/5 mg tablet, 30 | Is a | empagliflozin 10 mg + linagliptin 5 mg tablet, 30 | true | Inferred relationship | Some | ||
| Glyxambi 10 mg/5 mg tablet, 30 | has TPUU | Glyxambi 10 mg/5 mg tablet | true | Inferred relationship | Some | 1 | |
| Glyxambi 10 mg/5 mg tablet, 30 | has TP | Glyxambi 10 mg/5 mg | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Glyxambi 10 mg/5 mg tablet, 30, blister pack | Is a | True | Glyxambi 10 mg/5 mg tablet, 30 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR